# PDE6C

## Overview
PDE6C is a gene that encodes the protein phosphodiesterase 6C, which is a cone-specific cyclic GMP phosphodiesterase. This enzyme plays a pivotal role in the phototransduction pathway within cone photoreceptor cells of the human retina, facilitating the conversion of light signals into electrical signals. As a member of the phosphodiesterase family, PDE6C is characterized by its regulatory GAF domains and a C-terminal catalytic domain, which are essential for its function in hydrolyzing cGMP. This process is crucial for the regulation of ion channels and the hyperpolarization of photoreceptor cells in response to light. Mutations in the PDE6C gene are linked to retinal disorders such as achromatopsia, which is marked by impaired color vision and reduced visual acuity (Muradov2009Characterization; Grau2010Decreased).

## Structure
The PDE6C protein is primarily expressed in cone photoreceptor cells and plays a crucial role in the phototransduction pathway. Its molecular structure includes several key features. The protein contains two regulatory GAF domains at the N-terminal, which are involved in cGMP binding and regulation of the enzyme's activity (Martinez2008The). The GAF A domain has a typical fold with a six-stranded antiparallel β-sheet and two helices forming a cGMP-binding pocket (Martinez2008The). This domain is monomeric in solution and undergoes significant conformational changes upon cGMP binding, which enhances its thermodynamic stability (Martinez2008The).

The PDE6C protein also includes a C-terminal catalytic domain, which is conserved across species and shares structural similarities with PDE5 (Grau2010Decreased). The protein's structure is stabilized by interactions such as hydrogen bonds and hydrophobic contacts, with key residues like Asn-116 and Thr-172 playing a role in cGMP binding (Martinez2008The). Post-translational modifications, such as prenylation, are important for its membrane association and localization within photoreceptor cells (Cheguru2013The). PDE6C can form a homodimer, contributing to its quaternary structure (Cheguru2013The).

## Function
The PDE6C gene encodes a protein that functions as a cone-specific cyclic GMP phosphodiesterase in the human retina. This enzyme plays a critical role in the phototransduction process, which is essential for converting light signals into electrical signals in cone photoreceptor cells. Upon light stimulation, the photopigment activates the G-protein transducin, which in turn activates PDE6C by displacing its inhibitory subunit. The activated PDE6C hydrolyzes cGMP, leading to the closure of cGMP-gated ion channels and hyperpolarization of the photoreceptor plasma membrane (Muradov2009Characterization; Grau2010Decreased).

PDE6C is specifically involved in cone photoreceptors, which are responsible for color vision and function optimally in bright light conditions. The enzyme is a catalytic dimer composed of two identical α'-subunits and is predominantly membrane-bound in cone cells (Muradov2009Characterization). The regulation of PDE6C activity involves interactions with transducin and the inhibitory γ-subunit, as well as post-translational modifications (Cote2021Photoreceptor). Mutations in the PDE6C gene can lead to autosomal recessive achromatopsia, characterized by the loss of cone photoreceptor function, reduced visual acuity, photophobia, and impaired color discrimination (Grau2010Decreased).

## Clinical Significance
Mutations in the PDE6C gene are associated with several cone photoreceptor disorders, primarily achromatopsia (ACHM) and cone dystrophy (CD). ACHM is a congenital or early-onset retinal disorder characterized by symptoms such as reduced visual acuity, photophobia, nystagmus, and color vision defects. These symptoms result from the dysfunction of cone photoreceptors due to mutations in PDE6C, which encodes a crucial component of the phototransduction cascade in cones (Weisschuh2018Mutations; Grau2010Decreased).

Specific mutations in PDE6C, such as missense mutations p.R29W and p.Y323N, have been identified in patients with early-onset cone disorders. These mutations affect conserved residues involved in cGMP binding and enzyme regulation, leading to impaired phototransduction and cone cell dysfunction (Thiadens2009Homozygosity). The p.E790K and p.Y323N mutations, for example, result in decreased catalytic activity of the enzyme, further contributing to the clinical manifestations of ACHM (Grau2010Decreased).

PDE6C mutations are relatively rare compared to other genes associated with ACHM, such as CNGA3 and CNGB3, but they still contribute significantly to the mutation spectrum of this condition (Weisschuh2018Mutations). The absence of foveal hypoplasia in PDE6C-associated ACHM distinguishes it from other forms of the disorder (Georgiou2019Deep).

## Interactions
Phosphodiesterase 6C (PDE6C) is involved in several protein interactions crucial for its function in the phototransduction pathway. One significant interaction is with the gamma subunit of PDE6 (Pγ), which plays a regulatory role. The GAF A domain of PDE6C contains a conserved surface patch that is suggested to interact with the polycationic region of Pγ, a component of the phototransduction cascade (Martinez2008The). This interaction is important for the regulation of PDE6C activity and stability.

Mutations in PDE6C can disrupt its interactions with Pγ, affecting the protein's functionality. For instance, mutations like R29W and Y323N significantly reduce Pγ's ability to act as a co-chaperone, leading to lower yields of functional protein (Gopalakrishna2017Mechanisms). These mutations are linked to achromatopsia, a condition characterized by impaired cone photoreceptor function.

PDE6C also interacts with PDE6D, a prenyl-binding protein essential for photoreceptor cell trafficking. This interaction is crucial for the proper localization and function of PDE6C within photoreceptor cells (Gopalakrishna2017Mechanisms). These interactions highlight the complex regulatory network in which PDE6C participates, ensuring proper visual signal transduction.


## References


[1. (Cheguru2013The) Pallavi Cheguru, Zhongming Zhang, and Nikolai O. Artemyev. The gafa domain of phosphodiesterase‐6 contains a rod outer segment localization signal. Journal of Neurochemistry, 129(2):256–263, November 2013. URL: http://dx.doi.org/10.1111/jnc.12501, doi:10.1111/jnc.12501. This article has 8 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/jnc.12501)

[2. (Gopalakrishna2017Mechanisms) Kota N. Gopalakrishna, Kimberly Boyd, and Nikolai O. Artemyev. Mechanisms of mutant pde6 proteins underlying retinal diseases. Cellular Signalling, 37:74–80, September 2017. URL: http://dx.doi.org/10.1016/j.cellsig.2017.06.002, doi:10.1016/j.cellsig.2017.06.002. This article has 38 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cellsig.2017.06.002)

[3. (Muradov2009Characterization) Hakim Muradov, Kimberly K. Boyd, Mohammad Haeri, Vasily Kerov, Barry E. Knox, and Nikolai O. Artemyev. Characterization of human cone phosphodiesterase-6 ectopically expressed in xenopus laevis rods. Journal of Biological Chemistry, 284(47):32662–32669, November 2009. URL: http://dx.doi.org/10.1074/jbc.m109.049916, doi:10.1074/jbc.m109.049916. This article has 23 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m109.049916)

[4. (Cote2021Photoreceptor) Rick H. Cote. Photoreceptor phosphodiesterase (pde6): activation and inactivation mechanisms during visual transduction in rods and cones. Pflügers Archiv - European Journal of Physiology, 473(9):1377–1391, April 2021. URL: http://dx.doi.org/10.1007/s00424-021-02562-x, doi:10.1007/s00424-021-02562-x. This article has 21 citations.](https://doi.org/10.1007/s00424-021-02562-x)

[5. (Weisschuh2018Mutations) Nicole Weisschuh, Katarina Stingl, Isabelle Audo, Saskia Biskup, Béatrice Bocquet, Kari Branham, Marie S Burstedt, Elfride De Baere, Meindert J De Vries, Irina Golovleva, Andrew Green, John Heckenlively, Bart P Leroy, Isabelle Meunier, Elias Traboulsi, Bernd Wissinger, and Susanne Kohl. Mutations in the gene pde6c encoding the catalytic subunit of the cone photoreceptor phosphodiesterase in patients with achromatopsia. Human Mutation, 39(10):1366–1371, August 2018. URL: http://dx.doi.org/10.1002/humu.23606, doi:10.1002/humu.23606. This article has 16 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.23606)

[6. (Thiadens2009Homozygosity) Alberta A.H.J. Thiadens, Anneke I. den Hollander, Susanne Roosing, Sander B. Nabuurs, Renate C. Zekveld-Vroon, Rob W.J. Collin, Elfride De Baere, Robert K. Koenekoop, Mary J. van Schooneveld, Tim M. Strom, Janneke J.C. van Lith-Verhoeven, Andrew J. Lotery, Norka van Moll-Ramirez, Bart P. Leroy, L. Ingeborgh van den Born, Carel B. Hoyng, Frans P.M. Cremers, and Caroline C.W. Klaver. Homozygosity mapping reveals pde6c mutations in patients with early-onset cone photoreceptor disorders. The American Journal of Human Genetics, 85(2):240–247, August 2009. URL: http://dx.doi.org/10.1016/j.ajhg.2009.06.016, doi:10.1016/j.ajhg.2009.06.016. This article has 156 citations.](https://doi.org/10.1016/j.ajhg.2009.06.016)

[7. (Georgiou2019Deep) Michalis Georgiou, Anthony G. Robson, Navjit Singh, Nikolas Pontikos, Thomas Kane, Nashila Hirji, Caterina Ripamonti, Tryfon Rotsos, Alfredo Dubra, Angelos Kalitzeos, Andrew R. Webster, Joseph Carroll, and Michel Michaelides. Deep phenotyping ofpde6c-associated achromatopsia. Investigative Opthalmology &amp; Visual Science, 60(15):5112, December 2019. URL: http://dx.doi.org/10.1167/iovs.19-27761, doi:10.1167/iovs.19-27761. This article has 52 citations.](https://doi.org/10.1167/iovs.19-27761)

[8. (Grau2010Decreased) Tanja Grau, Nikolai O. Artemyev, Thomas Rosenberg, Hélène Dollfus, Olav H. Haugen, E. Cumhur Sener, Bernhard Jurklies, Sten Andreasson, Christoph Kernstock, Michael Larsen, Eberhart Zrenner, Bernd Wissinger, and Susanne Kohl. Decreased catalytic activity and altered activation properties of pde6c mutants associated with autosomal recessive achromatopsia. Human Molecular Genetics, 20(4):719–730, December 2010. URL: http://dx.doi.org/10.1093/hmg/ddq517, doi:10.1093/hmg/ddq517. This article has 52 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddq517)

[9. (Martinez2008The) Sergio E. Martinez, Clemens C. Heikaus, Rachel E. Klevit, and Joseph A. Beavo. The structure of the gaf a domain from phosphodiesterase 6c reveals determinants of cgmp binding, a conserved binding surface, and a large cgmp-dependent conformational change. Journal of Biological Chemistry, 283(38):25913–25919, September 2008. URL: http://dx.doi.org/10.1074/jbc.m802891200, doi:10.1074/jbc.m802891200. This article has 42 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m802891200)